Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $11.7200 (12.05%) ($10.6500 - $11.7600) on Sat. Apr. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.19% (three month average) | RSI | 62 | Latest Price | $11.7200(12.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 2.4% a day on average for past five trading days. | Weekly Trend | TGTX advances 5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TGTX price | TGTX will decline at least -3.595% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.595% (StdDev 7.19%) | Hourly BBV | 0 () | Intraday Trend | 8% | | | |
|
5 Day Moving Average | $10.57(10.88%) | 10 Day Moving Average | $10.21(14.79%) | 20 Day Moving Average | $9.87(18.74%) | To recent high | -26.7% | To recent low | 64.1% | Market Cap | $N/A | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |